IFLR is part of Legal Benchmarking Limited, 1-2 Paris Garden, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement


Position: Senior Partner
Rating:
  • Notable practitioner
Practice Areas:
Private equity
M&A
Jurisdictions:
Languages:
Chinese
English
Biography

Mr. Xuezhong Lu is a senior partner of AllBright Law Offices with his base in Shanghai. He is one of the co-heads of the Cross-border Investment Professional Committee of the firm. He also serves as an off-campus mentor for Master of Law students at East China University of Political Science and Law.

Mr. Lu specializes in overseas investment, cross-border investment and M&A, corporate restructuring, private equity and venture capital, etc., involved in industries such as healthcare and pharmaceutical, real estate, TMT, high-end manufacturing, retail and consumer. He has about 20 years of experience in the aforementioned practice areas and industries.

Mr. Lu has represented many Fortune 500 companies, international and domestic well-known investment institutions and corporate groups in a series of cross-border transactions, including the entry and implementation of major foreign investment projects, the organization and implementation of complex overseas investments and acquisitions, cross-border investment and M&A transactions, red-chip structures and other types of corporate restructuring, private equity and venture capital investments and financing, investment and financing and compliance operations of pharmaceutical and healthcare companies, real estate companies development and operation, data protection and compliance, etc.

Recent matter/case highlights
  • Advised Lilly Asia Ventures, one of the world’s leading life sciences and healthcare venture capital fund, on its equity investments in more than a dozen pharmaceutical companies.
  • Provided legal services to Hong Fu Asset’s funds for investment projects in over ten medical health and pharmaceutical enterprises including Bozhiyanxin, Changfeng Imaging, Jiangyin Jiyuan, Chongqing Qinsong, Yafei, Wangshan Wangshui, etc.
  • Advised KKR on various investment projects in China.
Key practice areas
  • Investment funds
  • M&A
  • Private equity
  • Private equity funds
  • Project development
  • Real estate finance
  • Real estate funds
Sector expertise
  • Automotive
  • Construction and materials
  • Consumer goods and services
  • Food and beverage
  • Healthcare
  • Industrials
  • Investment management
  • Natural resources
  • Pharmaceutical and life sciences
  • Real estate
  • Technology and telecommunications
Academic qualifications
  • LLB, East China University of Political Science and Law, 2005
  • LLM, East China University of Political Science and Law, 2008
  • LLM, Columbia Law School, 2016
Bar admissions
  • PRC Bar, 2008
  • New York Bar, 2017
Address:
9,11,12/F, Shanghai Tower No.501,
Yincheng Middle Road, Pudong New Area,
Shanghai, 200120
Tel:+862120511645 Email:Contact this practitioner Website:https://www.allbrightlaw.com/EN/0502/b8bd8c9532a549e3ad27c31dd83ea5fd.aspx